All Type of News
Korea Eximbank to support hidden champions
The Export-import Bank of Korea (Korea Eximbank) plans to nurture 300 hidden champions with high potential, to become competitive global players by 2020.
Eximbank has played a leading role in tackling the issue by ...
Drugmakers, wholesalers to face joint anti-rebate investigations
Sooner or later, pharmaceutical companies and wholesalers are likely to face the government’s intensive campaigns aimed at curbing rebates and lowering drug prices.
Participating in this campaign are not just the ...
GSK to strengthen presence in Asia with new strategic alliance with Dong-A
With a strategic alliance with Dong-A Pharmaceuticals Co. (Dong-A) in May, GlaxoSmithKline (GSK) has a plan to promote the latter’s proprietary and generic pharmaceutical products and leading consumer healthcare brand...
Green Cross, MacroGenics sign exclusive license agreement to develop and commercialize Herceptin Bio
Green Cross Corporation and US-based MacroGenics Inc. announced on July 8 an agreement to grant Green Cross exclusive rights to develop and commercialize MGAH22, a next-generation and Fc-optimized mAB that targets HER...
HIRA prohibits prescription of 4,084 medicines
The Health Insurance Review and Assessment Service (HIRA) has recently announced that 4,084 drugs, such as atorvastatin 80 mg and rosuvastatin 10 mg, should not be indicated for use during pregnancy.
HIRA official...
Deregulation on joint, commissioned bioequivalence testing stirs debate
The government’s plan to deregulate the joint, commissioned bioequivalence testing has stirred up concerns among drug companies.
They fear that the new plan could not only slash their profits amid entry of too many...
Drugmakers’ lukewarm response angers wholesalers
Pharmaceutical wholesalers have argued that the unified distribution system should be further extended, but they feel alienated from the Korea Pharmaceutical Manufacturers Association (KPMA)’s cold shoulder.
Their ...
KFDA to strengthen microbiological contamination related GMP standards
The Korea Food and Drug Administration says it has revised written procedures of current good manufacturing practice (cGMP), designed to prevent microbiological contamination of drug products purporting to be sterile....
KFDA nods Amosartan as first-line antihypertensive drug
The Korea Food and Drug Administration approved the homegrown anti-hypertension combination drug “Amosartan” as a first-line drug in patients with more than moderate hypertension (systolic blood pressure; more than 16...
Korea veers into health food market
A local professor said Korea will enter the promising health food market together with local research institutes backed by the government, it was learned on July 7.
The Ministry of Knowledge Economy said it would ...
